July 7, 2020 / 5:23 AM / in a month

BRIEF-Novartis Gets European Commission Approval For Enerzair Breezhaler Asthma Treatment

July 7 (Reuters) - Novartis AG:

* NOVARTIS RECEIVES EC APPROVAL FOR ENERZAIR® BREEZHALER®, INCLUDING FIRST DIGITAL COMPANION (SENSOR AND APP) THAT CAN BE PRESCRIBED ALONGSIDE A TREATMENT FOR UNCONTROLLED ASTHMA IN EU Source text for Eikon: Further company coverage: (Reporting by Berlin Speed Desk)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below